把″药″卖进″种胚″里！种子处理已升级为系统化解决方案
农化行业的竞争，正悄然从田间地头转向一粒种子。当传统植保产品陷入同质化与价格战的泥潭，全球巨头已不约而同地将种子处理视为新的战略高地。从UPL的专利布局到巴斯夫的生物发酵工厂，一场围绕″入口″的卡位战已经打响。这不仅是技术的较量，更是商业模式的重构。
全球玉米害虫防控的差异化实践：美洲困于Bt抗性、非洲低成本适配、亚洲规模化生防
世界农化网中文网报道：玉米作为全球产量居首的谷物作物，是粮食、饲料及工业原料的重要基石。然而，全球化贸易、气候变暖与农业集约化单作模式的叠加效应，正深刻重塑害虫发生格局——草地贪夜蛾等跨境入侵害虫已造成非洲年损失25亿至63亿美元，亚洲玉米螟在中国单年即可导致600万至900万吨减产；与此同时，西方玉米根虫、玉米螟等本土害虫对化学农药及Bt蛋白的抗性演化持续加速。由于各大洲在生态条件、经济水平与技术可及性上存在显著差异，玉米害虫防控已呈现鲜明的区域分异特征。
从”限定”到”放开”：EX登记2.0版重塑出口登记格局
2026年6月12日，扬州。农业农村部第1020号公告发布近一个月后，农业农村部农药检定所党委副书记赵可利在中国农药发展与应用协会举办的行业会议上对EX登记制度新要求进行了系统宣贯。赵可利将本次调整定性为2020年EX登记1.0版基础上的2.0版——大稳定、小调整，整体符合并稳定了行业预期。
浙江省出台石化化工行业转型升级实施意见
近日，浙江省印发了《石化化工行业转型升级的实施意见(2026—2028年)》，提出到2028年，力争行业规模稳步增长，精细化工率提升至65%，单位工业增加值能耗、碳排放强度分别较2025年下降6%和12%。
13个成分、8个境外来源、4种代谢物：加拿大重新划定三唑类杀菌剂的安全边界
2026年6月，加拿大卫生部有害生物管理局（PMRA）正式发布REV2026-02文件，启动三唑类杀菌剂累积健康风险评估（Cumulative Risk Assessment，CRA）的实施方案。这是继2024年10月CRA启动通知之后，PMRA首次将累积风险评估框架完整应用于一个大类杀菌剂。此次评估的覆盖范围分三层：13个在加拿大境内已登记的三唑类成分，进入定量评估；8个可能通过进口食品产生残留的境外成分，通过四步决策树评估后进入定量或定性评估；另有16个境外成分因残留不相关被排除。三类共37个三唑类品种进入不同程度的筛选流程。
Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments
Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million in milestone payments for the artificial intelligence-based drug design company whose “lab-in-the-loop” approach combines AI with a continuous feedback loop of experimental wet-lab data.
K-State Agricultural Economist Says SOil Health Practices May Go Hand-in-hand With Farm Profitability
June 2026, Bucyrus: As more Kansas farmers consider practices like no-till and cover crops, a common question remains: D…
Amaggi Buys 40% Of Fs And Fully Enters The Corn Ethanol Market
June 2026, US: Amaggi has just announced the acquisition of 40% of FS, marking the most emblematic transaction in the hi…
Professor Pete Iannetta Elected Chair Of UK Legume Research Community
June 2026, UK: The Hutton is delighted to announce that Professor Pete Iannetta, a research leader in ecological feed an…
Korean pharma giants push derma cosmetics for piece of K-beauty pie
Derma cosmetics are emerging as a next big growth engine for K-beauty, and today, at the Global K Beauty Conference 2026 in Seoul, South Korea, industry representatives are discussing how to tap into it. The trend is already translating into market activity, with some Korean pharmaceutical companies introducing their own derma brands. Debut strategies in the space appear to be more aggressive than traditional pharmacy launches.